Scientists devoted to immuno-oncology are establishing new ways to target and destroy cancer cells through personalized immunotherapies. Thanks to decades of research and advances in technologies, scientists have richly documented the human adaptive and innate immune response mechanisms and are now using that information to design and administer personalized immunotherapies.